NEUROWAVE SYSTEMS, INC.

NeuroWave Systems, Inc. specializes in anaesthesia depth monitoring devices. Their portfolio includes standalone monitors like the NeuroSENSE and NeuroWave NeuroFAST MONITORING SYSTEM (Model NF-701), as well as integrated systems such as the DiscoverEEG System (Model DE-401) and the NeuroSENSE Monitoring System (Model NS-901). They also produce disposable EasyPrep electrodes, which are used for EEG monitoring. These devices leverage advanced signal processing to evaluate brain activity, aiding clinicians in managing anaesthesia safely and effectively.

NeuroWave Systems, Inc. is headquartered in the United States. Since the company operates in the U.S., its devices are subject to FDA regulations, including classification under FDA’s Class I and Class II categories. This regulatory framework ensures compliance with U.S. medical device standards, though individual devices must undergo their own authorization processes (e.g., 510(k) clearance or premarket approval) before they can be legally marketed.

NeuroWave Systems, Inc.’s devices are listed in three key regulatory databases: eudamed (for EU market access), FDA’s 510(k) pathway (for premarket notifications in the U.S.), and FDA’s Unique Device Identifier (UDI) database (to ensure traceability and compliance tracking). These listings are critical because they provide transparency on authorized devices, facilitate market surveillance, and help healthcare providers verify regulatory status before use.

NeuroWave Systems, Inc.’s devices fall under FDA Class I (generally low-risk, with minimal regulatory controls) and Class II (moderate-risk, requiring special controls to ensure safety and effectiveness). Class II devices, like some anaesthesia monitors, undergo 510(k) premarket notifications to demonstrate substantial equivalence to existing approved products, while Class I devices may only require registration and listing. The classification determines the regulatory pathway but does not imply automatic authorization—each device must still meet specific compliance criteria.

Yes, some of NeuroWave Systems, Inc.’s devices are intended for international use, as evidenced by their listing in eudamed, which is the EU’s central registry for medical devices. This listing is essential for market access in the European Economic Area (EEA), where devices must comply with EU MDR (Medical Device Regulation) requirements. While the U.S. and EU have separate regulatory frameworks, listings in both systems reflect the company’s efforts to ensure its products meet global standards for safety and performance.